BACKGROUND/OBJECTIVES: Dementia-related behavioral symptoms and functional dependence result in poor quality of life for persons with dementia and their caregivers. The goal was to determine whether a home-based activity program (Tailored Activity Program; TAP-VA) would reduce behavioral symptoms and functional dependence of veterans with dementia and caregiver burden. DESIGN: Single-blind (interviewer), parallel, randomized, controlled trial (Clinicaltrials.gov: NCT01357564). SETTING: Veteran's homes. PARTICIPANTS: Veterans with dementia and their family caregivers (N = 160 dyads). INTERVENTION: Dyads in TAP-VA underwent 8 sessions with occupational therapists to customize activities to the interests and abilities of the veterans and educate their caregivers about dementia and use of customized activity. Caregivers assigned to attention control received up to 8 telephone-based dementia education sessions with a research team member. MEASUREMENTS: Primary outcomes included number of behaviors and frequency of their occurrence multiplied by severity of occurrence; secondary outcomes were functional dependence, pain, emotional well-being, caregiver burden (time spent caregiving, upset with behaviors) and affect at 4 (primary endpoint) and 8 months. RESULTS: Of 160 dyads (n = 76 TAP-VA; n = 84 control), 111 completed 4-month interviews (n = 51 TAP-VA; n = 60 control), and 103 completed 8-month interviews (n = 50 TAP-VA; n = 53 control). At 4 months, compared
B
ehavioral symptoms, a core clinical feature of dementia, occur across disease etiologies and stages. 1 Symptoms result in significant disease burden and negative sequela including increased healthcare costs, reduced quality of life and functional dependence, rapid disease progression and more time spent caregiving, nursing home placement, and caregiver distress. [2] [3] [4] [5] [6] The Food and Drug Administration has not approved any pharmacological treatments. Off-label antipsychotic medications that are prescribed off label have risks, including stroke and mortality, that often outweigh their modest benefits. 7, 8 Pharmacological treatments also do not address behaviors distressful to families (rejection of care). Although nonpharmacological strategies are recommended as first-line treatment, it is unclear which approaches are effective.
Previously, we reported results of a pilot randomized trial testing the Tailored Activity Program (TAP), which matches activities to interests and preserved abilities of persons with dementia and instructs caregivers in their use. 4 Findings showed large effect sizes, statistically significant reductions in frequencies of behaviors and time spent caregiving, and cost effectiveness. [9] [10] [11] The trial involved a small sample (N = 60) and a wait-list control group, suggesting need for replication controlling for attention. Other activity studies with positive outcomes were conducted in nursing homes, with small samples, and with nonrandomized designs. 12 We report on a randomized trial testing whether TAP involving veterans with dementia (TAP-VA) reduced the number and frequency by severity of behavioral symptoms (primary outcomes) more than in an attention control group. We also evaluated whether TAP-VA slowed functional decline and reduced pain, time spent caregiving, and caregiver distress with behaviors. Finally, we examined whether 4-month benefits (main endpoint) remained at 8 months.
Dementia prevalence among veterans (5.8-9.4%) is comparable with that in the population at large, and dementia is associated with higher inpatient and outpatient service use. 13 Substantiating and expanding the evidence base for activity as a treatment option for addressing behavioral symptoms and daily function would improve dementia care.
METHODS
We conducted a single-blind, parallel, randomized, controlled trial comparing TAP-VA with an attention control using a 1:1 allocation ratio of participants to study groups. A trained interviewer masked to group allocation assessed participants at baseline and 4 and 8 months. Participants were aware of group assignments and asked not to discuss their assignment with the interviewer. Data safety monitoring boards and institutional review boards (IRBs) approved study and consent procedures and brochures.
14 Recruitment (2012-15) targeted caregivers of veterans' using geriatric Veteran Affairs (VA) services using mailings that included an IRB-approved study flyer and invitational letters from medical directors. Procedures were explained to caregivers contacting the research team, who were administered a telephone screen to determine eligibility. Eligible and willing caregivers underwent a home interview within 2 weeks, followed by randomization to TAP-VA or telephone-based education (attention control).
Eligible veterans were English speaking, had a MiniMental State Examination (MMSE) score of 23 or less, or a physician diagnosis of dementia were able to participate in 2 or more self-care activities; and were not involved in another study. Veterans taking medications from any of 4 classes of psychotropic medications (antidepressant, benzodiazepine, antipsychotic, anticonvulsant) or an antidementia medication (memantine, cholinesterase inhibitor) who were on a stable dose 60 days before enrollment were eligible.
Eligible caregivers were English-speaking primary caregivers aged 21 and older and living with the veteran, were accessible by telephone, planned to live in area for 8 months, were willing to learn activities, had managed 1 or more behavioral symptoms in past month, and were not participating in another study. Caregivers taking psychotropic medications who were on a stable dose 60 days before enrollment were eligible.
We stratified participants according to caregiver relationship to the veteran (spouse vs nonspouse) and then randomized within stratum. Randomization lists and two sets of randomization forms were prepared using opaque envelopes. Participants were randomized within 48 hours from baseline.
Interventions TAP-VA, described previously, 14 involved up to 8 in-home sessions delivered by occupational therapists (interventionists). Interventionists conducted assessments (2 sessions) of veterans (capabilities, executive and physical functioning, fall risk, daily routines, interests), caregivers (routines, employment, readiness), and environments (lighting, seating, clutter, noise). An assessment report and activity prescriptions detailing activity goals, how to set up the environment to support activities and specific strategies for their implementation were provided (four sessions). Graded activities drew upon preserved abilities and reduced task demands, enabling engagement by minimizing distress and sensory overload and compensating for executive dysfunctions. Through demonstration with veterans, caregivers learned to use activities, manage situational distress, and understand behavioral symptoms. In the last two sessions, caregivers learned to simplify activities for future declines and how to use strategies to other care challenges (bathing).
The attention control group participated in 8 telephone sessions with a masters-level team member with experience educating caregivers. Information was provided on relevant topics (home safety, dementia), with no discussion of activity or behavioral symptoms.
Outcomes
Primary endpoints included number and frequency by severity of behavioral symptoms. Using the Neuropsychiatric Inventory-Clinician (NPI-C), the presence of behaviors from 14 domains in the past month was assessed. A score reflecting total number of endorsed behaviors (range 0-14) was derived. For each endorsed behavior, caregivers reported frequency (0 = never to 4 = very frequently (≥1/ d), and severity (0 = none to 3 = major source of behavioral abnormality). A total score was derived by multiplying frequency by severity scores for each item and then summing across 142 items from 14 domains (alpha = 0.82, range = 0-1,704); higher scores indicated greater frequency by severity. 15 Functional dependence was measured using the Caregiver Assessment of Function and Upset Scale (CAFU). 16 Items included 8 instrumental activities of daily living (IADLs; telephone, shopping, meal preparation, housework, laundry, travel, medicine, managing finances) and 7 activities of daily living (ADLs; bathing, dressing upper and lower body, toileting, grooming, eating, getting in and out of bed). For activities, caregivers indicated whether veterans were independent (score = 7), had a safety concern (excessive time required, assistive devices used; score = 6), or needed supervision (set-up, cueing but no physical help; score = 5) or physical help (4 = a little, 25% assistance, 3 = moderate, 50% assistance, 2 = a lot, 75% assistance, or 1 = complete help, >75% assistance). A total functional dependence score was derived by summing across items and dividing by number of items (range 1-7). Lower scores represented greater dependence (alpha = 0.90). Subscale scores for IADL (alpha = 0.73) and ADL (alpha = 0.93) dependence were similarly derived.
We also calculated the number of ADLs and IADLs that veterans require assistance with (score<7), deriving a total mean number of activities requiring assistance (0-15; IADL range 0-8; ADL range 0-7).
Caregivers evaluated veterans' pain using four Pain Intensity Scale items (How much has pain or physical discomfort interfered with day-to-day activities?) on a 5-point scale (1 = not at all, 5 = extremely). 17 A total score was derived by summing across items. Scores range from 4 to 20; higher scores indicate more pain (alpha = 0.88).
Caregivers rated their perceptions of veteran's affect using 6 quality-of-life items on a 5-point scale (1 = never, 5 = several times per day). A total score was derived by summing across items. Scores range from 6 to 30; higher scores indicate greater frequency of positive emotion (alpha = 0.29). 18 We used the 10-item Centers for Epidemiologic Study Depression Scale (CES-D) for caregiver depression. Caregivers rated symptoms on a 4-point scale (0 = rarely or none of time, 3 = all of the time). 19 A total mean score was derived by summing across items. Scores range from 10 to 40; higher scores indicate greater symptomatology (alpha = 0.79). Burden was measured using the 12-item Zarit Burden Short Form scored as never (0) to nearly always (4) occurring. A total mean score was derived by summing across items. Scores range from 0 to 48; higher scores indicate greater burden (alpha = 0.87). 20 Time spent caregiving was measured according to number of hours providing ADL and IADL assistance, hours on duty, and and hours doing things for the veteran, caregivers estimated time in minutes and hours using a 24-hour day. 21 Finally, caregivers rated each occurring behavior on the NPI-C using on a 6-point scale (0 = not distressing, 5 = extremely distressing). A distress score was calculated as the mean of subscale averages for 14 behavioral domains. 15 
Procedures
Adverse events were tracked, interviews were checked for coding accuracy by three independent reviewers, and missing data and coding errors were resolved. Treatment fidelity was monitored using checklists applied to randomly selected (10%) case presentations at supervisory meetings for both groups. Completed intervention documentation was reviewed for protocol adherence. Interventionists did not have contact with the interviewer.
Statistical Analysis
Sample size calculation was based on the main study hypothesis tested at 80% power for a 2-sided alternative hypothesis using a t-test comparing the treatment groups on 4-month values. Based on previous trials, we sought a medium effect size of 0.50 using a type I error rate of .05.
Although this required 64 dyads per group, because of expected attrition (20%), we enrolled an additional 16 per group or 32 dyads (N = 160 dyads, 80 dyads per group).
We conducted descriptive analyses and univariate comparisons between the treatment and control groups using chi-square and Wilcoxon rank-sum tests, as appropriate. Descriptive statistics were used to examine potential differences between eligible individuals willing and not willing to participate and between completers and non-completers by 4 months. Analyses were used to characterize sample demographics, evaluate comparability between treatment arms or success of randomization in balancing groups, and determined the effect of noncompleters on that balance due to potentially important prognostic factors.
We performed a primary intention-to-treat analysis to examine the effect of treatment on NPI-C (number of behaviors, total frequency-by-severity score), using analysis of covariance (ANCOVA), adjusting for prespecified covariates (caregiver relationship, baseline NPI-C score, propensity score of dropping out). The propensity score was calculated using logistic regression, with dropping out as the dependent variable and baseline characteristics found to be different between groups (Supplementary  Table S2 ) as predictors. For ANCOVA analysis, we calculated adjusted mean differences between groups on the outcome change (baseline to 4 months). All 160 randomized study dyads were used in the analyses, with missing outcomes at 4 months imputed using predicted values from a regression model of significant baseline characteristics. Specifically, for imputing NPI-C total scores at 4 months, predictors included ADL and IADL dependence, caregiver number of medicines, and baseline frequency-byseverity behavior score. ADL dependence, caregiver strategy use score, and baseline number of behavioral symptoms were used to predict number of behavioral symptoms at 4 months.
For each primary outcome, sensitivity analysis was conducted comparing the above results with those obtained from complete-case-only analysis. For secondary aims, we followed a similar approach, imputing missing data and then estimating treatment effects based on ANCOVA or logistic regression. Analyses were performed using SAS version 9.2 (SAS Institute, Inc., Cary NC). Statistical tests were 2-sided, with a significance level of .05.
RESULTS
Of 248 inquiries, 231 (93.1%) dyads were screened over the telephone, of which 164 (71.0%) were eligible. At baseline, 4 dyads were ineligible, resulting in 160 dyads eligible and willing to participate (n = 76 TAP-VA; n = 84 controls) (Figure 1) . By 4 months, 111 (69.4%) dyads were available (51 = TAP; 60 = controls), and 49 (31.2%) were unavailable (25 = TAP; 24 = controls). There were statistically significant differences at baseline between completer and noncompleter caregivers at 4 months. Noncompleters cared for veterans with more functional dependence, behavioral symptoms, financial strain, caregiver burden, and caregiving hours than completers (all P's<.05). Noncompleters were more likely to care for older (P = .09) and non-Hispanic (P = .10) veterans. (Supplementary Table S1) JAGS FEBRUARY 2018-VOL. 66, NO. 2 RANDOMIZED CLINICAL TRIAL FOR DEMENTIA CAREBy 8 months, 103 (64.4%) dyads were available for follow-up (n = 50 TAP; n = 53 controls). Total attrition was 57 (35.6%) caregivers (n = 26 TAP; n = 31 controls).
Caregivers had an average age of 72.4 AE 10.6, and 156 (97.5%) were female, 129 (81.1%) were white, 139 (86.9%) were the veteran's spouse, 143 (89.4%) were unemployed, 61 (38.1%) had a high school education or less, and 66 (41.3%) had financial difficulties.
Veterans had an average age of 80.4 AE 8.7, and 155 (96.9%) were male, 127 (79.4%) were white, 149 (93.1%) were married, and 65 (40.6%) had a high school education or less. Veterans had an average MMSE score of 16.6 AE 7.8 (range 0-29), and 66 (41.3%) had fair to poor health (Supplementary Table S2 ).
Of 76 TAP-VA caregivers, 11 (15%) refused treatment: 6 for unknown reasons, 1 because of randomization, 2 because of nursing home placement, 1 because of caregiver health problems, and 1 changed his or her mind. Of the remaining caregivers (n = 65, 85%) with treatment data, an average of 7.02 AE 1.72 sessions and Unable to contact (9) 8-month follow up N= 53
Lost to Follow-Up (n =7)
Moved (1) Unable to reach (1) Nursing home placement (1) Veteran with dementia died (3) Changed mind (1) 4-month follow up (n=60)
Lost to Follow Up (n=24)
Geography (4) Extreme Agitation (1) Veteran with dementia moved to nursing home (2) Veteran with dementia died (7) Caregiver died ( 75.5 AE 26.6 minutes per session (range 15-180 minutes per session) were completed. Of TAP-VA group, 58.5% (n = 38) completed 8 sessions, 24.6% (n = 16) 7 sessions, 0.7% (n = 1) 6 sessions, 3.1% (n = 2) 5 sessions, 7.7% (n = 5) 4 sessions, and 4.6% (n = 3) 3 or fewer sessions; 62 dyads completed more than 3 sessions, considered minimal for treatment effect. Of 84 attention control caregivers, 1 refused treatment because of time commitment (1.0%). Average call time was 18.2 AE 7.0 minutes (range = 8-57). The remaining 83 control caregivers completed an average of 7.05 AE 1.98 sessions and 18.2 AE 7.0 minutes per session. Seventy-eight of the initial 84 (92.9%) completed 4 or more sessions and 6 (7.1%) completed fewer than 4.
Veteran Outcomes
At 4 months, greater improvement occurred in number of behavioral symptoms (between-group difference, change from baseline to 4 months = À0.68, 95% CI = À1.23 to À0.13, P = .02) and frequency by severity scores (difference = À.24.3, 95% CI = À45.6 to À3.1, P = .02) for TAP-VA participants than the control group. After adjusting for baseline frequency by severity score, veteran age, and caregiver relationship (spouse vs nonspouse), we estimated that 69.7% of TAP-VA participants showed improvement (elimination of behaviors or reduction in frequency by severity scores), compared with 46.4% of controls. The number needed to treat to prevent one additional bad outcome was 4.7.
We observed greater improvements in TAP-VA veterans than controls for all secondary outcomes except affect. Reductions were found in number of functional activities requiring assistance (difference = À0.80, 95% CI = À1.41 to À0.20, P = .009), functional dependence (difference = 4.09, 95% CI = 1.06, 7.13, P = .009), and pain (difference = À1.18, 95% CI = À2.10 to À0.26, P = .01) ( Table 1) .
Caregiver Outcomes
At 4 months, TAP-VA caregivers had less distress with behavioral symptoms than controls (difference = À0.07, 95% CI = À0.14 to À0.01, P = .03). TAP-VA caregivers did not improve statistically significantly more than controls in depression, burden, or time caregiving, although all change scores favored intervention (Table 2) .
There were no differences between TAP-VA and the attention control group at 8 months.
DISCUSSION
Activities customized to interests and abilities immediately improved clinical features of dementia (behavioral symptoms, functional dependence), with no adverse events. We found a preventive effect (fewer behavioral symptoms at 4 months for TAP-VA participants than controls), a maintenance effect (TAP-VA caregivers provided assistance with a similar number of ADLs at 4 months whereas controls reported increases in assistance required), reductions in frequency by severity of behaviors and pain, and slowing of functional dependence. TAP-VA also benefited caregivers by reducing distress with behavior. Results are consistent with those of other TAP trials (initial pilot, TAP-hospital, 22 TAP Brazil, 23 TAP-Australia), 24 extending reported benefits to pain and functional dependence.
It is disappointing that 4-month benefits did not endure to 8 months, yet expectations for long-term effects may be unrealistic without repeated exposure to the treatment (activity engagement). Unlike pharmacotherapies, activity use depends upon caregivers. We could not determine whether caregivers discontinued activity use or activities needed modifications.
Why do customized activities reduce behavioral symptoms, improve function, and decrease pain? The etiology of symptoms is unclear. Conceptual models suggest that symptoms are consequences of heightened vulnerabilities to physical and social environments due to neurodegenerative processes. 25 Customized activities may help veterans remain physically active, reducing pain, and meaningfully engaged with purpose, an enduring need. 26 Instructing caregivers in ways to support function may reduce dependency. 27 Future research should identify the underlying mechanisms by which tailored activities have their effects, including neurobiological links. Activities may affect gene expression networks and cellular health, 28 physiological stress, 29 and circadian rhythms, 30 which are potential pathways as to how activity engagement may have its effects.
Study limitations include use of a single veteran setting, small sample size, and that medication change effects are unclear. We relied on caregiver self-report, although state-of-the-science and psychometrically sound measures were used. Furthermore, noncompleters were more distressed and financially strained than completers and reported more behavioral symptoms and functional dependencies. The differential between noncompleters and completers brings into question the generalizability of results and also if exposure to TAP-VA eariler on in the disease progress is warranted.
A different dropout rate between study arms and higher-than-expected attrition resulted in loss of power, with some findings not reaching statistical significance. Because TAP-VA caregivers received more attention than control group caregivers, contributions of attention to outcomes are unclear.
Regardless of limitations, because poor treatment options for behavioral symptoms and functional dependence are limited, TAP-VA offers a viable approach for addressing behavioral symptoms and functional declines, affording important immediate benefits to veterans and caregivers.
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